Detalhe da pesquisa
1.
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
N Engl J Med
; 390(1): 20-31, 2024 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916620
2.
A Proliferation Inducing Ligand (APRIL) targeted antibody is a safe and effective treatment of murine IgA nephropathy.
Kidney Int
; 96(1): 104-116, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31027890
3.
Factors affecting response and tolerability to ferumoxytol in nondialysis chronic kidney disease patients.
Clin Nephrol
; 78(3): 181-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22874106
4.
Mitochondrial DNA injury and mortality in hemodialysis patients.
J Am Soc Nephrol
; 20(1): 189-96, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-18684894
5.
Ferumoxytol for treating iron deficiency anemia in CKD.
J Am Soc Nephrol
; 19(8): 1599-605, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18525001
6.
KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.
Am J Kidney Dis
; 52(5): 811-25, 2008 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-18971009
7.
Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
Am J Nephrol
; 28(4): 677-83, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18354252
8.
Plasma adiponectin levels and clinical outcomes among haemodialysis patients.
Nephrol Dial Transplant
; 23(8): 2619-28, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18334528
9.
Protective effect of intravenous levocarnitine on subsequent-month hospitalization among prevalent hemodialysis patients, 1998 to 2003.
Am J Kidney Dis
; 50(5): 803-12, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17954293
10.
Dose requirements among hemodialysis patients treated with darbepoetin-alpha or epoetin-beta.
Nephron Clin Pract
; 107(2): c50-5, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17713351
11.
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.
Am Heart J
; 149(3): 408-13, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15864229
12.
Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease?
Am J Kidney Dis
; 45(1): 136-47, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15696453
13.
Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients.
Am J Kidney Dis
; 45(2): 324-33, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15685511
14.
Effect of comorbidity on the increased mortality associated with early initiation of dialysis.
Am J Kidney Dis
; 46(5): 887-96, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16253729
15.
Relationship of urine output to dialysis initiation and mortality in acute renal failure.
Nephron Clin Pract
; 99(2): c56-60, 2005.
Artigo
em Inglês
| MEDLINE | ID: mdl-15637430
16.
Death in the first year after kidney transplantation: implications for patients on the transplant waiting list.
Transplantation
; 75(1): 113-7, 2003 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12544882
17.
Why do preemptive kidney transplant recipients have an allograft survival advantage?
Transplantation
; 78(6): 873-9, 2004 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-15385807
18.
Hospitalization during advancing chronic kidney disease.
Am J Kidney Dis
; 42(5): 972-81, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14582041
19.
Chronic kidney disease in the United States: an underrecognized problem.
Semin Nephrol
; 22(6): 441-8, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12430088
20.
Overcoming barriers to the early detection and treatment of chronic kidney disease and improving outcomes for end-stage renal disease.
Am J Manag Care
; 8(4 Suppl): S122-35; quiz S136-9, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11924569